APA

Emonts M., de Bruijne E. L. E., Guimarães A. H. C., Declerck P. J., Leebeek F. W. G., de Maat M. P. M., Rijken D. C., Hazelzet J. A. & Gils A. (20080501). Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. : Journal of thrombosis and haemostasis : JTH.

Chicago

Emonts M, de Bruijne E L E, Guimarães A H C, Declerck P J, Leebeek F W G, de Maat M P M, Rijken D C, Hazelzet J A and Gils A. 20080501. Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. : Journal of thrombosis and haemostasis : JTH.

Harvard

Emonts M., de Bruijne E. L. E., Guimarães A. H. C., Declerck P. J., Leebeek F. W. G., de Maat M. P. M., Rijken D. C., Hazelzet J. A. and Gils A. (20080501). Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. : Journal of thrombosis and haemostasis : JTH.

MLA

Emonts M, de Bruijne E L E, Guimarães A H C, Declerck P J, Leebeek F W G, de Maat M P M, Rijken D C, Hazelzet J A and Gils A. Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. : Journal of thrombosis and haemostasis : JTH. 20080501.